The History of Irreversible Non-Selective MAOI Antidepressants in Russia (for their 70th Anniversary)

The history of irreversible non-selective MAOI antidepressants in the USSR and Russia is systemized. The history of representatives’ appearance is described. The history of the study of pharmacological effects is highlighted. The history of the study of clinical effects in various mental disorders is analyzed in chronological order. The history of use in somatic pathology is summarized. The history of the use of special pharmaceutical forms is considered. The history of new experimental compounds creation is submitted. The features of history of irreversible non-selective MAOI antidepressants in the USSR and Russia in comparison with their history in other countries are characterized.

1. Avrutskii G.Ya., Vovin R.Ya., Lichko A.E., Smulevich A.B. Biologicheskaya terapiya psikhicheskikh zabolevanii. L.: Meditsina. 1975. (In Russ.).

2. Avrutskii G.Ya., Gurovich I.Ya., Gromova V.V. Farmakoterapiya psikhicheskikh zabolevanii. M.: Meditsina. 1974. (In Russ.).

3. Avrutskii G.Ya., Neduva A.A. Lechenie psikhicheski bol›nykh: Rukovodstvo dlya vrachei (2-e izdanie). M.: Meditsina. 1988. (In Russ.).

4. Avrutskii G.Ya., Neduva A.A. Lechenie psikhicheski bol›nykh: Rukovodstvo dlya vrachei. M.: Meditsina. 1981. (In Russ.).

5. Belkin A.I. Lechenie psikhicheskikh rasstroistv pri endokrinnykh zabolevaniyakh etaperazinom, frenolonom i parnatom. V sb.: Psikhofarmakologiya i lechenie nervnykh i psikhicheskikh zabolevanii (materialy konferentsii, 9-12 dekabrya 1964 g.). Red. T.Ya. Khvilitskii, Yu.L. Nuller. L.: Gosudarstvennyi nauchno-issledovatel’skii psikhonevrologicheskii institut im. V.M. Bekhtereva. 1964. (In Russ.).

6. Belousov Yu.B., Moiseev V.S., Lepakhin V.K. Klinicheskaya farmakologiya i farmakoterapiya (rukovodstvo dlya vrachei). M.: Universum. 1993. (In Russ.).

7. Bobrov AE, Shurygin AN, Krasil›nikov SV. Study of the effectiveness of the combined use of monoamine oxidase inhibitors and psychotherapy in the treatment of chronic alcoholism. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1991;91(2):79-83. (In Russ.).

8. Bukreev VI. The effect of pyridoxine on the psychopathology and pathochemistry of depression in involutionary age. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1978;78(3):402-408. (In Russ.).

9. Burdakova EA, Vedernikova NA, Kornilaeva NP. On the antidepressant action of transamine (preliminary report). Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1962;62(12):1813-1814. (In Russ.).

10. Burnazyan G.A. Psikhofarmakoterapiya. Erevan: Aistan. 1980. (In Russ.).

11. Burov Yu.V. Iprazid. V kn.: Bol’shaya meditsinskaya entsiklopediya (tret’e izdanie, glav. red. B.V. Petrovskii). T.9. M.: Sovetskaya entsiklopediya. 1978. (In Russ.).

12. Vainshtein AE. Antidepressants in the treatment of stress disorders (literature review). Psikhiatriya i psikhofamakoterapiya. 2005;7(2):86-8. (In Russ.).

13. Valeeva LA, Davlyatova GG, Shabalina YuV, Isakova AV, Khaliullin FA, Nikitina IL. Synthesis and antidepressant properties of 2-[3-methyl7-(thietanyl-3)-1-ethylxanthinyl-8-thio]acetic acid hydrazides. Himiko-farmacevticheskij zhurnal. 2016;50(6):8-11. (In Russ.). https://doi.org/10.30906/0023-1134-2016-50-6-811

14. Vein A.M., Dyukova G.M., Vorob’eva O.V., Danilov A.B. Panicheskie ataki (nevrologicheskie i psikhofiziologicheskie aspekty) (obshch. red. A.M. Vein). SPb.: Institut meditsinskogo marketinga. 1997. (In Russ.).

15. Vengerskie lekarstvennye preparaty. Budapesht: Medimpeks. 1967. (In Russ.).

16. Vengerskie lekarstvennye preparaty. Budapesht: Medimpeks. 1989. (In Russ.).

17. Voloshin V.M., Mosolov S.N. Sovremennye podkhody k terapii posttravmaticheskogo stressovogo rasstroistva (na primere primeneniya sertralina). V kn.: Novye dostizheniya v terapii psikhicheskikh zabolevanii (red. S.N. Mosolov). M.: Binom. 2002. (In Russ.).

18. Votchal B.E. Ocherki klinicheskoi farmakologii (vtoroe izdanie). M.: Meditsina. 1965. (In Russ.).

19. Gilev AP, Terekhina AI, Tarasova EI, Khavronina ZP. Experimental study of the pharmacological properties of nialamide. Farmakologiya i toksikologiya. 1967;30(3):328-31. (In Russ.).

20. Grinshtein VYa, Ratenberg NS, Morozova TN. Data from experimental and clinical studies of a new monoamine oxidase inhibitor—transamine. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1962;62(12):1806-1812. (In Russ.).

21. Gromova V.V. O lechenii depressivnykh sostoyanii transaminom (parnatom). V kn.: Voprosy psikhofarmakologii: Trudy MNII psikhiatrii MZ RSFSR (red. D.D. Fedotov). T. 49. M.: MNII psikhiatrii. 1967. (In Russ.).

22. Gromova V.V. Sravnitel›nye dannye o klinicheskom deistvii nekotorykh antidepressivnykh sredstv. V sb.: Psikhofarmakologiya i lechenie nervnykh i psikhicheskikh zabolevanii (materialy konferentsii, 9-12 dekabrya 1964 g.) (red. T.Ya. Khvilitskii, Yu.L. Nuller). L.: Gosudarstvennyi nauchnoissledovatel’skii psikhonevrologicheskii institut im. V.M. Bekhtereva. 1964. (In Russ.).

23. Dobrzhanskaya AK. Therapy of depression with iprazid. Zhurnal nevropatologii i psikhiatrii im S.S. Korsakova. 1959;59(12):485-8. (In Russ.).

24. Zaidel’ K., Kulavik Kh., Shakhmatov N.F., Bobrova I.N. Maniakal’no-depressivnyi psikhoz. V kn.: Rukovodstvo po psikhiatrii (red. G.V. Morozov), T.1. M.: Meditsina. 1988. (In Russ.).

25. Zakusov V.V. Farmakologiya tsentral›nykh sinapsov. M.: Meditsina. 1973. (In Russ.).

26. Ivanchenko FT, Kovaleva NI. The effect of niamide on patients with atherosclerosis with a primary lesion of the coronary vessels. Vrachebnoe delo. 1965;1:63-67. (In Russ.).

27. Il’yuchenok RYu. The effect of iprazide on the bioelectrical activity of the brain. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1959;59(8):972979. (In Russ.).

28. Isaev DN, Voronkov BV. History of the Department of Psychiatry of the Leningrad Pediatric Medical Institute (on the 50th anniversary of its founding). Zhurnal nevropatologii i psikhiatrii im S.S. Korsakova. 1988;88(8):120-123. (In Russ.).

29. Kalinin V.V. Sovremennaya farmakoterapiya trevozhnykh sostoyanii. V kn.: Novye dostizheniya v terapii psikhicheskikh zabolevanii (red. S.N. Mosolov). M.: Binom. 2002. (In Russ.).

30. Kovalev V.V. Psikhiatriya detskogo vozrasta (rukovodstvo dlya vrachei). M.: Meditsina. 1979. (In Russ.).

31. Kokosov AN. Clinical trial of felazin in angina pectoris. Kardiologiya. 1965;5(1):85‐86. (In Russ.).

32. Kontsevoi VA, Andrusenko MP. Clinical gerontopsychopharmacology: achievements and problems (review of foreign studies). Zhurnal nevropatologii i psikhiatrii im S.S. Korsakova. 1989;89(9):127-138. (In Russ.).

33. Kudrin AN, Koroza GS, Kost AN, Sagitullin RS. Vetrazine as a uterine stimulant. Farmakologiya i toksikologiya. 1963;26(1):75-80. (In Russ.).

34. Kudrin AN, Koroza GS, Orlov IV, Ryabokon NA. On the neurotropic effect of 3,4-dimethoxybenzylhydrazine (Vetrazine). Farmakologiya i toksikologiya. 1964;27:160-165. (In Russ.).

35. Lapin IP, Samsonova ML. Comparison of pharmacological activity and toxicity of antidepressants nialamide, phenelzine and iproniazid. Farmakologiya i toksikologiya. 1969;32(5):526-530. (In Russ.).

36. Leibovich FA. Changes in the bioelectrical mosaic of the cerebral cortex in depressed patients during treatment with iprazide. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1959;59(12):14701479. (In Russ.).

37. Lekarstvennye sredstva, primenyaemye v meditsinskoi praktike v SSSR (vtoroe izdanie) (red. M.A. Klyuev). M.: Meditsina; 1989. (In Russ.).

38. Liberman SS. Effect of iprazide on the hypothermic and sedative effects of reserpine and chlorpromazine. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1959;59(4):396-401. (In Russ.).

39. Liberman SS. On the pharmacology of felazin, a monoamine oxidase inhibitor. Farmakologiya i toksikologiya. 1962;25(2):175-179. (In Russ.).

40. Maksimovich Ya.B. Propisyvanie, nesovmestimost’ i pobochnoe deistvie lekarstvennykh sredstv (izdanie 2). Kiev: «Zdorov’ya». 1974. (In Russ.).

41. Masliev A.T., Yumasheva Yu.S., Gal’perina R.E., Drobizhev Yu.Z. Lechenie niamidom (nialamidom) depressivnykh sostoyanii. V sb.: Terapiya psikhicheskikh zabolevanii (Trudy 1-go Moskovskogo ordena Lenina meditsinskogo instituta imeni I.M. Sechenova, T. XXV). M.: 1-i Moskovskii ordena Lenina meditsinskii institut imeni I.M. Sechenova. 1963. (In Russ.).

42. Mashkovskii MD. Iprazide, its pharmacological properties and clinical application. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1959;59(4):385-95. (In Russ.).

43. Mashkovskii M.D. Lekarstvennye sredstva (10-e izd.). T. 1. M.: Meditsina. 1987. (In Russ.).

44. Mashkovskii M.D. Lekarstvennye sredstva (izdanie 8). T.1. M.: Meditsina. 1977. (In Russ.).

45. Mashkovskii MD, Andreeva NI, Polezhaeva AI. Monoamine oxidase inhibitors as drugs. Khimiko-farmatsevticheskii zhurnal. 1980; 14 (2): 6-12. (In Russ.).

46. Mashkovskii M.D., Andreeva N.I., Polezhaeva A.I. Farmakologiya antidepressantov. M.: Meditsina. 1983. (In Russ.).

47. Mileikovskii Yu.A., Lavrovskaya N.A. Vtorichnaya profilaktika alkogolizma nuredalom. V sb.: Novye metody terapii i reabilitatsii psikhicheski bol›nykh vo vnebol›nichnykh usloviyakh (Tezisy dokladov Vserossiiskoi konferentsii, Krasnoyarsk, 1979 g., red. G.Ya. Avrutskii). M.: Vserossiiskoe nauchnoe meditsinskoe obshchestvo nevropatologov i psikhiatrov, Moskovskii NII psikhiatrii MZ RSFSR. 1979: 109-10. (In Russ.).

48. Mikhailova TV, Gilev AP, Khavronina-Gureeva ZP. Central effects of betamizide. Farmakologiya i toksikologiya. 1969;32(6):652-6. (In Russ.).

49. Mikhalenko I.N., Nuller Yu.L. Differentsirovannaya terapiya endogennoi depressii. V sb.: Psikhofarmakologiya i lechenie nervnykh i psikhicheskikh zabolevanii (materialy konferentsii, 9-12 dekabrya 1964 g.) (red. T.Ya. Khvilitskii, Yu.L. Nuller). L.: Gosudarstvennyi nauchno-issledovatel’skii psikhonevrologicheskii institut im. V.M. Bekhtereva. 1964. (In Russ.).

50. Morozova TN. Treatment of depression with iprazid. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1959;59(12):1480-4 (In Russ.).

51. Morozova T.N. O farmakoterapii depressivnykh sostoyanii. V kn.: Voprosy psikhofarmakologii (Trudy Gosudarstvennogo nauchno-issledovatel’skogo instituta psikhiatrii ministerstva zdravookhraneniya RSFSR, T. XXXV) (red. D.D. Fedotov). M.: Ministerstvo zdravookhraneniya RSFSR, Gosudarstvennyi nauchno-issledovatel’skii institut psikhiatrii. 1962. (In Russ.).

52. Mosolov S.N. Klinicheskoe primenenie sovremennykh antidepressantov. S-Pb.: Meditsinskoe informatsionnoe agentstvo. 1995. (In Russ.).

53. Mosolov SN. Modern trends in the development of psychopharmacotherapy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 1998;98(5):12-9. (In Russ.).

54. Mosolov SN. Ethical aspects of clinical trials of psychotropic drugs. Sotsial’naya i klinicheskaya psikhiatriya. 1995;5(2):119-123. (In Russ.).

55. Mukhina NA, Gilev AP, Klimenko VG. Synthesis of tersavid. Meditsinskaya promyshlennost’ SSSR. 1965;19(7):9-11. (In Russ.).

56. Mukhina NA, Klimenko VG, Gilev AP, Terekhina AI. Synthesis of niamide. Meditsinskaya promyshlennost’ SSSR. 1965;19(5):10-12. (In Russ.).

57. Nadzharov R.A., Morozova T.N., Smulevich A.B. O problemakh klinicheskoi psikhofarmakologii. V kn.: Voprosy psikhofarmakologii (Trudy Gosudarstvennogo nauchno-issledovatel’skogo instituta psikhiatrii ministerstva zdravookhraneniya RSFSR, T. XXXV) (red. D.D. Fedotov). M.: Ministerstvo zdravookhraneniya RSFSR, Gosudarstvennyi nauchnoissledovatel’skii institut psikhiatrii. 1962. (In Russ.).

58. Nuller Yu.L. Otsenka effektivnosti fenetalzina (fenelzina) pri endogennoi depressii. Trudy Leningradskogo nauchno-issledovatel’skogo psikhonevrologicheskogo instituta imeni V.M. Bekhtereva. T. XXXIV (red.: I.P. Lapin, T.Ya. Khvilitskii; obshch. red.: M.M. Kabanov, V.N. Myasishchev). Leningrad: Izdatel’stvo «Meditsina» Leningradskoe otdelenie. 1966. (In Russ.).

59. Nuller Yu.L., Mikhalenko I.N. Affektivnye psikhozy. M.: Meditsina. 1988. (In Russ.).

60. Panteleeva G.P. Lechenie, profilaktika i organizatsiya pomoshchi. V razdele: Affektivnyi psikhoz. V kn.: Rukovodstvo po psikhiatrii (red. A.S. Tiganov). T.1. M.: Meditsina. 1999. (In Russ.).

61. Panteleeva G.P. Psikhofarmakologicheskie sredstva. V kn.: Bol’shaya meditsinskaya entsiklopediya (izdanie tret’e, glav. red. Petrovskii B.V.). T.21. M.: Sovetskaya entsiklopediya. 1984. (In Russ.).

62. Prokhorova IS. Some aspects of differentiated therapy of circular depressions. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1985;85(4):570-4. (In Russ.).

63. Psikhiatricheskaya pomoshch’ pri zemletryaseniyakh: Metodicheskie rekomendatsii (red. Yu.A. Aleksandrovskii). M.: MZ SSSR. 1989. (In Russ.).

64. Raiskii V.A. Psikhotropnye sredstva v klinike vnutrennikh boleznei. M.: Meditsina. 1982. (In Russ.).

65. Raiskii VA, Kasatkina LV, Grigor’yants RA, Livshits NYa. Nuredal in the treatment of coronary heart disease. Kardiologiya. 1977;17(3):137-8. (In Russ.)

66. Saarma Yu.M. Deistvie melipramina, parnata i parstelina na neirodinamiku zdorovykh lits. V sb.: Problemy psikhonevrologii (nauchnye trudy) (red. L.G. Ursova). M.: 1-i MMI im. I.M. Sechenova. 1969. (In Russ.).

67. Semina II, Baichurina AZ. Development of new potential drugs with psychotropic activity among phosphorylacetohydrazides and other phosphorylated carboxylic acids derivatives—priority area of Kazan school of psychopharmacologists. Kazanskii meditsinskii zhurnal. 2016;97(1):148-55. (In Russ.).

68. Spravochnik nevropatologa i psikhiatra (red. N.I. Grashchenkov, A.V. Snezhnevskii) (izdanie vtoroe). M.: Meditsina. 1968. (In Russ.).

69. Timofeev N. Maniakal›no-depressivnyi psikhoz. V kn.: Bol›shaya meditsinskaya entsiklopediya (izdanie vtoroe, red. A.N. Bakulev). T.16. M.: Gosudarstvennoe nauchnoe izdatel›stvo «Sovetskaya entsiklopediya». 1960. (In Russ.).

70. Khaunina R.A. Antidepressanty—ingibitory monoaminoksidazy. V kn.: Antidepressanty i lechenie depressivnykh sostoyanii (psikhofarmakologicheskie i klinicheskie issledovaniya). Trudy Leningradskogo nauchno-issledovatel’skogo psikhonevrologicheskogo instituta imeni V.M. Bekhtereva. T. XXXIV. (red.: I.P. Lapin, T.Ya. Khvilitskii; obshch. red.: M.M. Kabanov, V.N. Myasishchev). Leningrad: Izdatel’stvo «Meditsina» Leningradskoe otdelenie. 1966. (In Russ.).

71. Khvilitskii TYa, Nuller YuL. Experience in the use of niamide in the treatment of depressive conditions. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1968;68(9):1387-90. (In Russ.).

72. Shamanina VM, Lobova EK. To a comparative assessment of the action of niamide in parenteral and oral use in the clinic of depressive patients. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1964;64(9):1408-1413. (In Russ.).

73. Shternberg E.Ya. Psikhofarmakologiya. V kn.: Bol›shaya meditsinskaya entsiklopediya (izdanie vtoroe, glav. red. A.N. Bakulev). T.27. M.: Sovetskaya entsiklopediya. 1962. (In Russ.).

74. Shchelkunov E.L. Niamidnyi sindrom kak test predskazaniya psikhotropnoi aktivnosti. V kn.: Mekhanizmy mozga v norme i patologii (Tezisy dokladov respublikanskoi nauchnoi konferentsii 5-6 oktyabrya). Minsk: Minskoe oblastnoe nauchno-tekhnicheskoe obshchestvo radiotekhniki, elektroniki svyazi im. A.S. Popova, Minskii gosudarstvennyi meditsinskii institut, Sovet po avtomatizatsii nauchnykh issledovanii AN BSSR. 1972. (In Russ.).

75. Entin G.M. Lechenie alkogolizma i organizatsiya narkologicheskoi pomoshchi. M.: Meditsina. 1979. (In Russ.).

76. Yakovleva AI, Shakhnazarova NG, Mashkovskii MD. The influence of some derivatives of isonicotinic acid hydrazide on the content of serotonin in enterochromaffin cells of the intestine (Kulchitsky cells). Farmakologiya i toksikologiya. 1960;23(2):143-146. (In Russ.).

77. André A, de Souza e Almeida C. O empêgo do transamin (Trans-AMCHA), na cirurgia oral, em hemofílicos. Nota prévia. Hospital (Rio J). 1969;75(3):1101-1103.

78. Ayd FJ Jr. A preliminary report on marsilid. Am J Psychiatry. 1957;114(5):459. https://doi. org/10.1176/ajp.114.5.459

79. Bazire S. Psychotropic drug directory 2003/04. The professionals’ pocket handbook and aid memoire. Salisbury: Fivepin Publishing. 2003.

80. Gillman PK. Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors. J Clin Psychopharmacol. 2011;31(1):66-74. https://doi.org/10.1097/JCP.0b013e31820469ea

81. Holt A, Berry MD, Boulton AA. On the binding of monoamine oxidase inhibitors to some sites distinct from the MAO active site, and effects thereby elicited. Neurotoxicology. 2004;25(1-2):251-266. https://doi.org/10.1016/s0161-813x(03)00104-9

82. Kamman GR, Freeman JG, Lucero RJ. The effect of l-isonicotynil-2-isopropyl hydrazine (IIH) on the behavior of long-term mental patients. J Nerv Ment Dis. 1953;118(5):391-407. https://doi.org/10.1097/00005053-19531100000002

83. Kielholz P. Treatment for masked depression. Psychopharmacol Bull. 1975;11(1):31-34.

84. Kline NS. Clinical experience with iproniazid (marsilid). J Clin Exp Psychopathol. 1958;19(2, Suppl 1):72-8;discussion78-9.

85. Larsen JK, Krogh-Nielsen L, Brøsen K. The monoamine oxidase inhibitor isocarboxazid is a relevant treatment option in treatment-resistant depressionexperience-based strategies in Danish psychiatry. Health Care Cur Rev. 2016;4(2). https://doi.org/10.4172/2375-4273.1000168

86. Loomer HP, Saunders JC, Kline NS. A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer. Psychiatr Res Rep Am Psychiatr Assoc. 1957;8:129-141.

87. Maass AR, Nimmo MJ. A new inhibitor of serotonin metabolism. Nature. 1959;184(Suppl 8):547548. https://doi.org/10.1038/184547b0

88. Petersen MC, McBrayer JW. Treatment of affective depression with trans-dl-phenylcyclopropylamine hydrochloride; a preliminary report. Am J Psychiatry. 1959;116(1):67-68. https://doi.org/10.1176/ajp.116.1.67

89. Phelps J, Carlat D. Four “new” antidepressants. Or are they? Tablet. 2011;12(3):2-9. https://doi.org/10.1037/e625792012-002

90. Robinson PW. The fate of Vetrazin® (cyromazine) during woolscouring and its effects on the aquatic environment. A thesis submitted in fulfilment of the requirements for the degree of doctor of philosophy. Christchurch: Lincoln University. 1995.

91. Smith JA. The use of the isopropyl derivative of isonicotinylhydrazine (marsilid) in the treatment of mental disease; A preliminary report. Am Practitioner Dig Treat. 1953;4(8):519-520.

92. Stolberg VB. ADHD medications: history, science, and issues. Santa Barbara: Greenwood. 2017.

93. Tedeschi RE, Tedeschi DH, Ames PL, Cook L, Mattis PA, Fellows EJ. Some pharmacological observations on tranylcypromine (SKF trans-385), a potent inhibitor of monoamine oxidase. Proc Soc Exp Biol Med. 1959;102(2):380-381. https://doi.org/10.3181/00379727-102-25256

94. Thase ME. The role of monoamine oxidase inhibitors in depression treatment guidelines. J Clin Psychiatry. 2012;73(Suppl 1):10-16. https://doi.org/10.4088/JCP.11096su1c.02

95. Wright V, Walker WC, Wood EA. Nialamide as a “Steroid Sparing” agent in the treatment of rheumatoid arthritis. Ann Rheum Dis. 1963;22(5):348353. https://doi.org/10.1136/ard.22.5.348